Blue Apron Holdings (NASDAQ:APRN) had its buy rating reaffirmed by analysts at Canaccord Genuity. They currently have a $11.00 price target on the stock, down from their previous price target of $14.00.

Broadcom Limited (NASDAQ:AVGO) had its buy rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $270.00 price target on the stock.

Maxim Group initiated coverage on shares of Can Fite Biopharma (NASDAQ:CANF). The firm issued a buy rating and a $7.00 target price on the stock.

Chromadex Corp (OTCMKTS:CDXC) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $5.00 price target on the stock. The analysts wrote, “We note that the company’s revenues came in at $5.3M vs. our original forecast of $8M, while a net loss of $2.7M or $0.07 per share was also recorded vs. our projection for a positive EPS of $0.04. While R&D spending in the quarter was roughly in-line with our estimate at $728K vs. $700K, we note that COGS were slightly worse than our estimate, coming in at 57% vs. our projection of 49%. Given what we see as the current status of ChromaDex’s ingredients business, we have revised our 2017 revenue number to $24.3M, while we now project a net loss per share for 2017 of $0.14 vs. our prior forecast for EPS of $0.16 for the year.””

Check-Cap (NASDAQ:CHEK) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $6.00 price target on the stock. The analysts wrote, “We note that this trial is designed to evaluate C-Scan’s ability to detect polyps as compared to colonoscopy. We expect a total data package of around 150 subjects to be submitted for CE Mark approval, which may potentially lead to European market entry in 2018. In the wake of this update, we reiterate our Buy rating and $6 price target. GE Healthcare collaboration awarded $1M grant. Check-Cap and GE Healthcare (GE; not rated) received approval of a $1M conditional grant from the Israel-U.S. Binational Industrial Research and Development Foundation (BIRD). The grant is to support development of a high- volume manufacturing process for the C-Scan system’s X-ray source and capsule assembly, and establish a unique product distribution process for a pilot clinical trial in the U.S.””

Piper Jaffray Companies initiated coverage on shares of Cinemark Holdings (NYSE:CNK). The firm issued a buy rating and a $44.00 price target on the stock.

CSX Corporation (NASDAQ:CSX) had its buy rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $65.00 price target on the stock.

Piper Jaffray Companies started coverage on shares of Discovery Communications (NASDAQ:DISCA). Piper Jaffray Companies issued a hold rating and a $27.00 target price on the stock.

Domino's Pizza Group PLC. (LON:DOM) had its outperform rating reissued by analysts at Credit Suisse Group. Credit Suisse Group currently has a GBX 365 ($4.75) target price on the stock.

Bottomline Technologies (NASDAQ:EPAY) had its hold rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $29.00 target price on the stock.

Noodles & (NASDAQ:NDLS) had its hold rating reiterated by analysts at Wedbush.

NVIDIA Corporation (NASDAQ:NVDA) had its buy rating reissued by analysts at Needham & Company LLC. The analysts wrote, “We believe NVIDA is the future computing platform company, servicing broad markets via its unified CUDA ecosystem and experiencing growth across all business segments. We remain confident in its gaming division growth (eSports, gaming laptops, gaming in the cloud) and see particular strength in its automotive roadmap (both AI cockpit and future ADAS/AV) as well as new applications within the data center division as Volta now targets the inference market.””

NVIDIA Corporation (NASDAQ:NVDA) had its buy rating reiterated by analysts at Loop Capital. Loop Capital currently has a $181.00 target price on the stock. The analysts wrote, “We think investors’ concerns that data center growth has slowed and topped out are unwarranted as FQ2 was a transition quarter to Volta. With Volta ramped, we are modeling a return to double-digit growth in FQ3. We are also cautious on how much more legs the demand from crypto currency mining has and we are modeling that business to flatten out in FQ3 and decline -20% YoY in F2019. We expect strong demand in data center and gaming in F2019 to more than offset the declines of crypto and we are modeling 14% YoY and 25% YoY growth, respectively. As for the step-up in OpEx, we believe NVDA must continue to spend to maintain its leadership position. We believe there is leverage in the model in F2019 driven by revenue growth and expanding margins.””

Points International (NASDAQ:PCOM) (TSE:PTS) had its buy rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $15.00 target price on the stock.

Stephens started coverage on shares of Sprouts Farmers Market (NASDAQ:SFM). The firm issued an equal weight rating on the stock.

SiteOne Landscape Supply (NYSE:SITE) had its buy rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $63.00 target price on the stock.

Snap (NYSE:SNAP) had its equal weight rating reiterated by analysts at Barclays PLC. They currently have a $13.00 target price on the stock, down from their previous target price of $18.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Synthomer PLC (LON:SYNT) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 525 ($6.84) price target on the stock.

Stephens started coverage on shares of United Natural Foods (NASDAQ:UNFI). They issued an equal weight rating on the stock.

Viveve Medical (NASDAQ:VIVE) had its buy rating reiterated by analysts at Maxim Group. Maxim Group currently has a $11.00 price target on the stock.

Wendy’s Company (The) (NASDAQ:WEN) had its hold rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $16.00 price target on the stock.